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Background: Cancer outcomes are complex, involving prevention, early detection and optimal multidis-
ciplinary care. Postoperative infection and surgical site-infection (SSI) are not only uncomfortable for
patients and costly, but may also be associated with poor oncological outcomes. A meta-analysis was
undertaken to assess the oncological effects of SSI in patients with colorectal cancer.
Methods: An ethically approved PROSPERO-registered meta-analysis was conducted following
PRISMA guidelines. PubMed and Scopus databases were searched for studies published between 2007
and 2017 reporting the effects of postoperative infective complications on oncological survival in colorec-
tal cancer. Results were separated into those for SSI and those concerning anastomotic leakage. Articles
with a Methodological Index for Non-Randomized Studies score of at least 18 were included. Hazard
ratios (HRs) with 95 per cent confidence intervals were computed for risk factors using an observed to
expected and variance fixed-effect model.
Results: Of 5027 articles were reviewed, 43 met the inclusion criteria, with a total of 154 981 patients.
Infective complications had significant negative effects on overall survival (HR 1⋅37, 95 per cent c.i. 1⋅28
to 1⋅46) and cancer-specific survival (HR 2⋅58, 2⋅15 to 3⋅10). Anastomotic leakage occurred in 7⋅4 per
cent and had a significant negative impact on disease-free survival (HR 1⋅14, 1⋅09 to 1⋅20), overall survival
(HR 1⋅34, 1⋅28 to 1⋅39), cancer-specific survival (HR 1⋅43, 1⋅31 to 1⋅55), local recurrence (HR 1⋅18, 1⋅06
to 1⋅32) and overall recurrence (HR 1⋅46, 1⋅27 to 1⋅68).
Conclusion: This meta-analysis identified a significant negative impact of postoperative infective com-
plications on overall and cancer-specific survival in patients undergoing colorectal surgery.
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Introduction
Colorectal cancer affects 17 people per 100 000 worldwide
and 30 per 100 000 in Europe1, with an average 5-year
survival rate of 65 per cent2. Optimizing cancer outcomes is
a complex interaction involving key strategies: prevention,
early detection and optimalmanagement3.Many treatment
paradigm shifts in both surgical and oncological treatment
have improved cancer outcomes. Recurrence, which affects
over 40 per cent of patients, has classically been associated
with tumour stage, grade, emergency presentation and
resection margin status4,5.
Surgical-site infections (SSIs), including superficial, deep
and organ space infections, are coming increasingly under
the spotlight, causing discomfort for patients and family,
anxiety for surgeons, and cost to healthcare systems6. In
addition, they are associated with potential delay in, or
omission of, adjuvant therapy.
A recent long-term analysis from the German Rectal
Cancer Trial7 suggested that surgical complications were
associated with both oncological and overall outcomes.
Immunological forces influence survival8. As SSI occurs
in approximately 15 per cent of patients undergoing
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Fig. 1 PRISMA flow chart showing selection of articles for review
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colorectal surgery, a clear understanding of any adverse
relationship is important9.
Although surgeons and patients alike fear the morbidity
and mortality associated with postoperative complications,
their potential negative impact on oncological outcomes
is not widely understood or reported routinely10,11. A
meta-analysis was undertaken to determine the impact
of postoperative infections on oncological outcomes in
colorectal cancer surgery.
Methods
A study was conducted to assess the impact of postoper-
ative infective complications on oncological outcomes in
colorectal cancer surgery. The study was registered with
PROSPERO (registration number: 42017069038) and fol-
lowed PRISMA guidelines12. PubMed and Scopus were
searched for studies that met the eligibility criteria. Origi-
nal articles, published between June 2007 and May 2017,
which reported the effect of infective complications on
oncological survival in both colonic and rectal cancer were
identified. The search strategy used the following key-
words: Colon Cancer, Colorectal Cancer, Rectal Cancer,
Complication, Infection, Oncological Outcomes, Anasto-
motic Leak, Survival and SSI. Animal studies, review arti-
cles, non-English papers, duplicate data sets and results
published only in abstracts were excluded. Details of the
search strategy and data management are available in
Tables S1 and S2 (supporting information).
Data extraction and quality assessment
The abstracts were screened by one author and full texts by
three authors. The descriptive and quantitative data from
the screened studies were extracted and papers were graded
using the Methodological Index for Non-Randomized
Studies (MINORS)13. The MINORS criteria have
been designed to assess the quality of comparative and
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Table 1 Study characteristics
Reference Country Study design
Multicentre database
study
No. of
patients
Anastomotic
leak
Bertelsen et al.17 Denmark Prospective Yes 1494 163 (10⋅9)
Cone et al.18 USA Prospective Yes 24 730
Espín et al.19 Spain Prospective Yes 1181 100 (8⋅5)
Jörgren et al.20 Sweden Prospective Yes 1977 172 (8⋅7)
Krarup et al.21 Denmark Prospective Yes 9333 593 (6⋅4)
Kube et al.22 Germany Prospective Yes 28 271 844 (3⋅0)
Aquina et al.23 USA Retrospective Yes 24 426
Artinyan et al.24 USA Retrospective Yes 12 075
Chu et al.25 USA Retrospective Yes 528
Nordholm-Carstensen et al.26 Denmark Retrospective Yes 774 71 (9⋅2)
Boccola et al.27 Australia Prospective No 1576 110 (7⋅0)
Duron et al.28 France Prospective No 3322
Eberhardt et al.29 USA Prospective No 177 59 (33⋅3)
Gong et al.30 China Prospective No 460 35 (7⋅6)
Gupta et al.31 Nepal Prospective No 272 18 (6⋅6)
Jannasch et al.32 Germany Prospective No 17867 2134 (11⋅9)
Law et al.33 China Prospective No 1657 47 (2⋅8)
Law et al.34 China Prospective No 1580 60 (3⋅8)
Platt et al.35 UK Prospective No 454
Ptok et al.36 Germany Prospective No 2044 303 (14⋅8)
Richards et al.37 UK Prospective No 423 18 (4⋅3)
Smith et al.38 USA Prospective No 1127 40 (3⋅5)
Smith et al.39 USA Prospective No 184 12 (6⋅5)
Thorgersen et al.40 Norway Prospective No 540
Attiê et al.41 Brazil Retrospective No 106
Ebinger et al.42 Switzerland Retrospective No 584 64 (11⋅0)
Goto et al.43 Japan Retrospective No 3364 85 (2⋅5)
Haruki et al.44 Japan Retrospective No 77
Huang et al.45 China Retrospective No 215
Jung et al.46 Korea Retrospective No 1391 35 (2⋅5)
Kang et al.47 Korea Retrospective No 1083 69 (6⋅4)
Katoh et al.48 Japan Retrospective No 1101
Kerin Povšicˇ et al.49 Slovenia Retrospective No 186
Kulu et al.50 Germany Retrospective No 570 51 (8⋅9)
Lee et al.51 Korea Retrospective No 1278 51 (4⋅0)
Lim et al.52 Korea Retrospective No 2510 141 (5⋅6)
Marra et al.53 Switzerland Retrospective No 445 12 (2⋅7)
McMillan et al.54 UK Retrospective No 920 24 (2⋅6)
Miccini et al.55 Italy Retrospective No 479 34 (7⋅1)
Mrak et al.56 Austria Retrospective No 811 54 (6⋅7)
Nachiappan et al.57 UK Retrospective No 1048 99 (9⋅4)
Noh et al.58 Korea Retrospective No 1258 101 (8⋅0)
Tsujimoto et al.59 Japan Retrospective No 1083 29 (2⋅7)
Total 154 981 7⋅4 (2⋅5–33⋅3)%*
Values in parentheses are percentages unless indicated otherwise; *values are mean (range).
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Fig. 2 Impact of surgical-site infection on overall survival
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non-comparative surgical studies using a three-point
scale (0, not reported; 1, reported but inadequate; 2,
reported and adequate), with assessment of eight items
for non-comparative studies and 12 items for compara-
tive studies. The ideal global scores for comparative and
non-comparative studies are 24 and 16 respectively.
Articles were graded by three reviewers initially, and only
those that scored at least 18 of 24 were included in the
statistical analysis. If there was disagreement on whether a
paper should be included or not, another reviewer graded
it and made the final decision. At the outset both rectal
and colonic cancer procedures were grouped into a single
category.
Results were separated into two key categories: infec-
tive complications (SSI, organ space infections, infectious
complications, sepsis) and anastomotic leakage. SSI was
defined according to the Centers for Disease Control
and Prevention14 definition, whereas anastomotic leak was
defined as reported in each article.
Overall survival, disease-free survival, cancer-specific
survival and cancer recurrence data were analysed for each
outcome where data were available and applicable. Survival
terms were defined in accordance with National Institutes
of Health–National Cancer Institute definitions15.
Statistical analysis
For oncological outcomes, hazard ratios (HRs) were taken
from papers or calculated using the MedCalc® statistical
calculator (MedCalc, Ostend, Belgium). Observed minus
expected (O-E) values and variance were calculated16, and
used to compute statistical values for use in the analysis.
Statistical analysis was performed in Review Manager
(RevMan) version 5 (Nordic Cochrane Centre, Cochrane
Collaboration, Copenhagen, Denmark) using O-E and
variance, a fixed-effect model for analysis and HR as effect
measure, with 95 per cent confidence intervals. Signifi-
cance was assessed at the two-sided 5 per cent level using
HRs. The complication has a significant effect on the mea-
sured oncological outcome if the 95 per cent confidence
interval of the HR does not include 1⋅00.
Results
A total of 5027 individual articles were reviewed in this
study (Fig. 1), of which 145 were found to be relevant and
underwent MINORS grading. Forty-three articles17–59
met all inclusion criteria and were used in the data ana-
lysis, with a total cohort size of 154 981 patients (Table 1).
Publications were from the USA (7), Korea (5), the UK
(4), Japan (4), China (4), Germany (4) and other countries
(15). There were 23 retrospective and 20 prospective stud-
ies in this meta-analysis. Ten studies were frommulticentre
databases (6 prospective, 4 retrospective).
Non-anastomotic infective complications
Sixteen papers reported SSI data that allowed meaningful
analysis. Of these, 11 of 16 papers contained data on overall
© 2020 The Authors. www.bjsopen.com BJS Open
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Fig. 3 Impact of anastomotic leakage on overall survival
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Fig. 4 Impact of anastomotic leakage on disease-free survival
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Fig. 5 Impact of anastomotic leakage on cancer-specific survival
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Fig. 6 Impact of anastomotic leakage on local recurrence
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Hazard ratios are shown with 95 per cent confidence intervals. A fixed-effect model was used for meta-analysis. O-E, observed to expected; V, variance;
AL, anastomotic leak; LR, local recurrence.
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Fig. 7 Impact of anastomotic leakage on overall recurrence
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survival. Three37,40,44 of 11 articles reported disease-free
survival and two23,41 of 11 articles cancer-specific survival.
Infective complications were shown to have a significant
negative effect on overall survival (HR 1⋅37, 95 per cent c.i.
1⋅28 to 1⋅46) (Fig. 2) and cancer-specific survival (HR 2⋅58,
2⋅15 to 3⋅10). However, there was no significant association
between infective complications and disease-free survival
(HR 0⋅89, 0⋅74 to 1⋅08).
Anastomotic leakage
Anastomotic leakage data were suitable for analysis in 31
publications. The mean leak rate was 7⋅4 (range 2⋅5–33⋅3)
per cent (Table 1). The effect of anastomotic leakage on
overall survival could be assessed in 24 articles, and its effect
on disease-free survival in ten of 31 studies. Cancer-specific
survival was reported in ten of 31 articles. Nineteen of the
31 articles reported on local recurrence and ten on overall
recurrence.
Anastomotic leakage had a negative impact on overall
survival (HR 1⋅34, 95 per cent c.i. 1⋅28 to 1⋅39) (Fig. 3),
disease-free survival (HR 1⋅14, 1⋅09 to 1⋅20) (Fig. 4),
cancer-specific survival (HR 1⋅43, 1⋅31 to 1⋅55) (Fig. 5),
local recurrence (HR 1⋅18, 1⋅06 to 1⋅32) (Fig. 6) and overall
recurrence (HR 1⋅46, 1⋅27 to 1⋅68) (Fig. 7).
Discussion
This meta-analysis of 154 981 patients in 43 studies eval-
uated the impact of both wound-related non-anastomotic
infective complications and anastomotic leakage, and iden-
tified a statistically significant negative oncological effect.
From the outset of this extensive literature review there
were a number of limitations. In the overall cohort, nar-
rowed by the quality of data and MINORS analysis, there
was significant heterogeneity. SSI definitions are problem-
atic, with variation from study to study. This is unfor-
tunately common in all forms of surgery. In a 20-year
period up to 2015, only 18 per cent of the top 50 cited
peer-reviewed publications on ventral hernia were found to
use a standardized definition of SSI and surgical-site occur-
rence after ventral hernia repair60,61. The absence of a com-
mon language impedes comparisons in the literature and
accuratemetrics of hospital qualitymeasures60. In addition,
the period of surveillance used to report SSI varies between
30 and 60 days42,60. Anastomotic leak itself has a heteroge-
neous spectrum of presentation, depending on the effort
made to detect leakage and the criteria used, whether based
on combined clinical, radiological or endoscopic features.
This may give rise to heterogeneity representing a poten-
tial limitation of this meta-analysis. Few articles, in gen-
eral, addressed the effect of SSI on oncological outcomes;
some evaluated overall survival, a few reported disease-free
survival and none considered the recurrence rate. Further-
more, owing to the limited numbers of papers, it was not
possible to undertake a subset analysis for different stages
of colorectal cancer, nor to differentiate between colonic
and rectal cancers.
The mean leak rate was 7⋅4 per cent across the 31
articles included in the analysis of anastomotic leak; this
is in keeping with the mean leak rate in international
data62. Anastomotic leakage is increasingly topical; there
have been paradigm shifts in surgical, prehabilitation,
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intraoperative and postoperative approaches to reducing
leakage62–64.
This meta-analysis reinforces the findings of a
meta-analysis65 in 2016, which showed that complica-
tion severity had a significant impact on both disease-free
and overall survival. Three other studies66–68 identified
a negative impact of anastomotic leakage on long-term
cancer-specific survival, particularly noting an increase in
local recurrence. Current efforts at SSI management after
colorectal surgery focus on compliance with guidelines and
evaluation of infection rates, but Gantz and colleagues69
recently suggested that improvement is needed. Mar-
tinez et al.70 suggested establishing national SSI bundles.
Historically, mechanical and oral bowel preparations
were favoured, but then bowel preparation went out of
vogue. Now there is the potential for reintroduction of
bowel cleansing and recognition of the importance of
other factors including those relating to the gut micro-
biome. The gut microbiome potentially has an effect
on infection and also a separate oncological effect. A
variety of environmental factors, including diet, antibi-
otics, bowel preparation and surgical stress, act on the
microbiome, altering its architecture and function, with a
negative effect on oncological outcomes after surgery71.
It is clear from the present data that anastomotic leak-
age is associated with increased local recurrence and
decreased overall survival. The recent German rectal trial
CAO/ARO/AIO-947 showed that surgical complications
are significantly associated with reduced overall survival.
Patients with complications are more likely to have distant
metastasis and local recurrences. The reason for this is
somewhat unclear, although it is known that cancer cells
shed from the bowel may embed themselves on stapling
devices, leading to enhanced tumour dissemination in
the event of anastomotic leak or reoperation. Exfoliated
cancer cells have been detected in the colonic lumen and
on stapling devices, suggesting that anastomotic leakage
could enhance dissemination72,73.
There are many confounders to the potential nega-
tive oncological effects of infection. Systemic inflamma-
tion has been shown to promote micrometastasis74. An
infection-led inflammatory cascade will activate cytokines,
and cell- and humoral-mediated immunity.
Local recurrence is an important clinical outcome for
patients with colorectal cancer; many treatment modal-
ities have been investigated with the aim of reducing
pelvic occurrence from total mesorectal excision to
neoadjuvant chemoradiotherapy. The present study has
identified that additional measures and routine use of SSI
prevention bundles need to be implemented to reduce
infective complications75. Infection prevention should
become a potential target for oncological improvement;
opportunities to reduce deep wound infection need to
be revisited, incorporating wound bundles, intraopera-
tive protective measures such as use of wound protectors,
potential antibiotic solution and rectal washouts, and closer
monitoring with intra-abdominal pressure measurement
after surgery.
This study had a number of limitations. An initial trawl
of the literature identified almost 13 000 potential publi-
cations. On deeper analysis, including qualitative evalua-
tion using the MINORS criteria, it was found that many of
these papers lacked a definition of either SSI or anastomotic
leakage60,61 and,most importantly, no relationship between
adverse events and oncological outcome was reported. In
contrast, it is increasingly being recognized in other fields
of oncology, such as breast cancer, that there may be a
relationship between infection and cancer recurrence76.
Surprisingly SSI data have not been included in cancer
registries. Uniform data definitions and data analysis would
make analysis easier. The small number of papers reporting
infective complications may have led to bias in the present
results. Subset analysis of SSI effects at different cancer
stages was not possible.
This meta-analysis has identified a statistically signifi-
cant association between both anastomotic leak and wound
infection/SSI and adverse oncological outcomes. Oncolog-
ical registries incorporating infective and adverse events
as part of their outcome analysis may help in understand-
ing the relationship between SSI and oncological out-
comes. Reduction in SSI may prove to be a noteworthy
part of adjuvant cancer therapy, and wound bundles should
become mandatory. There needs to be greater adoption
and monitoring of strategies that might reduce SSIs and
their negative impact.
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